Fourpath Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-67
Closed -$1.51K 584
2024
Q3
$1.51K Buy
+67
New +$1.51K ﹤0.01% 671